Literature DB >> 29952652

Alternating Current Iontophoresis for Control of Postoperative Pain.

Kazumasa Kubota1, Tomoyuki Miyamoto1, Takutoshi Inoue1, Haruhisa Fukayama1.   

Abstract

Control of early postoperative pain entails the use of various medications including acetaminophen, nonsteroidal anti-inflammatory drugs, selective cyclooxygenase-2 inhibitors, tramadol, and opioids. However, these medications should be carefully administered in patients with aspirin-exacerbated respiratory disease because some medications may trigger adverse reactions after maxillofacial surgeries. The goal of postoperative pain control in patients with aspirin-exacerbated respiratory disease is to eliminate pain without complications. Local anesthesia is an efficient tool for the control of postoperative pain after maxillofacial surgeries. We utilized a transdermal drug delivery system, iontophoresis by alternating current, in order to develop an alternative technique for administering local anesthetic to control postoperative pain in 2 patients with aspirin-exacerbated respiratory disease. A visual analogue scale was used to objectively measure the severity of pain. A 55-year-old woman who underwent mandibular wisdom tooth extraction and an 18-year-old woman who underwent sagittal split ramus osteotomy of the mandible both complained of pain multiple times. After application of iontophoresis, the visual analogue scale score was reduced to zero and postoperative pain could be controlled. There were no adverse events such as bronchospasm or skin irritation after the application of iontophoresis by alternating current.

Entities:  

Keywords:  Aspirin-exacerbated respiratory disease; Maxillofacial surgery; Postoperative pain; Transdermal drug transport

Mesh:

Substances:

Year:  2018        PMID: 29952652      PMCID: PMC6022798          DOI: 10.2344/anpr-64-04-03

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  21 in total

1.  Bupivacaine as pre-emptive analgesia in third molar surgery: Randomised controlled trial.

Authors:  M Sharif Nayyar; C Yates
Journal:  Br J Oral Maxillofac Surg       Date:  2006-02-02       Impact factor: 1.651

Review 2.  Opioid induced nausea and vomiting.

Authors:  Howard S Smith; Andras Laufer
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

3.  Lidocaine transport through living rat skin using alternating current.

Authors:  H Haga; T Shibaji; M Umino
Journal:  Med Biol Eng Comput       Date:  2005-09       Impact factor: 2.602

Review 4.  Trials and tribulations of skin iontophoresis in therapeutics.

Authors:  Matthieu Roustit; Sophie Blaise; Jean-Luc Cracowski
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

5.  Tramadol and acetaminophen tablets for dental pain.

Authors:  R A Medve; J Wang; R Karim
Journal:  Anesth Prog       Date:  2001

Review 6.  Aspirin-exacerbated respiratory disease and current treatment modalities.

Authors:  Emine Güven Sakalar; Nuray Bayar Muluk; Murat Kar; Cemal Cingi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-18       Impact factor: 2.503

Review 7.  Upper airways in aspirin-exacerbated respiratory disease.

Authors:  Jeong-Hee Choi; Ji-Hye Kim; Hae-Sim Park
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

8.  The relation between epinephrine concentration and the anesthetic effect of lidocaine iontophoresis.

Authors:  Ryo Wakita; Yuka Oono; Saori Oogami; Shizuka Hayashi; Masahiro Umino
Journal:  Pain Pract       Date:  2008-11-05       Impact factor: 3.183

9.  Traditional Japanese medicines inhibit compound action potentials in the frog sciatic nerve.

Authors:  Akitomo Matsushita; Tsugumi Fujita; Sena Ohtsubo; Eiichi Kumamoto
Journal:  J Ethnopharmacol       Date:  2015-12-17       Impact factor: 4.360

10.  Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis.

Authors:  S Reinauer; A Neusser; G Schauf; E Hölzle
Journal:  Br J Dermatol       Date:  1993-08       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.